HK1065719A1 - Use of thrombin-derived peptides for the therapy of chronic dermal ulcers - Google Patents

Use of thrombin-derived peptides for the therapy of chronic dermal ulcers

Info

Publication number
HK1065719A1
HK1065719A1 HK04108700A HK04108700A HK1065719A1 HK 1065719 A1 HK1065719 A1 HK 1065719A1 HK 04108700 A HK04108700 A HK 04108700A HK 04108700 A HK04108700 A HK 04108700A HK 1065719 A1 HK1065719 A1 HK 1065719A1
Authority
HK
Hong Kong
Prior art keywords
thrombin
therapy
chronic dermal
derived peptides
dermal ulcers
Prior art date
Application number
HK04108700A
Other languages
English (en)
Inventor
Darrell H Carney
Original Assignee
Orthologic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthologic Corp filed Critical Orthologic Corp
Publication of HK1065719A1 publication Critical patent/HK1065719A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK04108700A 2001-07-27 2004-11-05 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers HK1065719A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30819801P 2001-07-27 2001-07-27
PCT/US2002/001151 WO2003013569A2 (fr) 2001-07-27 2002-01-16 Procedes favorisant la cicatrisation d'ulceres dermiques chroniques

Publications (1)

Publication Number Publication Date
HK1065719A1 true HK1065719A1 (en) 2005-03-24

Family

ID=23192964

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04108700A HK1065719A1 (en) 2001-07-27 2004-11-05 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers

Country Status (12)

Country Link
US (3) US7049294B2 (fr)
EP (1) EP1414487B1 (fr)
JP (1) JP4192093B2 (fr)
CN (1) CN100509055C (fr)
AT (1) ATE328606T1 (fr)
AU (1) AU2002236768B2 (fr)
CA (1) CA2455756C (fr)
DE (1) DE60212143T2 (fr)
DK (1) DK1414487T3 (fr)
ES (1) ES2271216T3 (fr)
HK (1) HK1065719A1 (fr)
WO (1) WO2003013569A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100509055C (zh) * 2001-07-27 2009-07-08 奥索洛吉艾斯有限公司 使用凝血酶衍生的缩氨酸治疗慢性真皮溃疡
JP2006514822A (ja) * 2002-07-02 2006-05-18 ザ ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム トロンビンペプチド誘導体
DE60313982T2 (de) * 2002-07-02 2008-01-17 Orthologic Corp., Tempe Dimere von thrombinpeptidderivaten
JP5044829B2 (ja) 2003-12-31 2012-10-10 ザ ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム トロンビンペプチド誘導体のための医薬組成物
WO2007035406A1 (fr) * 2005-09-16 2007-03-29 Orthologic Corp. Anticorps pour des peptides complementaires de la thrombine ou de portions de celle-ci
WO2008124172A1 (fr) * 2007-04-10 2008-10-16 The Board Of Regents, The University Of Texas System Thérapie combinée pour les ulcères dermiques chroniques
US20110105400A1 (en) * 2008-03-26 2011-05-05 Orthologic Corp. Methods for treating acute myocardial infarction
WO2009120307A2 (fr) * 2008-03-26 2009-10-01 Orthologic Corp. Méthode de traitement de maladies artérielles périphériques
WO2009120300A2 (fr) * 2008-03-26 2009-10-01 Orthologic Corp. Procédé de traitement de maladies dégénératives
CA2722621A1 (fr) * 2008-03-26 2009-10-01 Orthologic Corp. Peptides derives de la thrombine pour relaxation des muscles lisses
GB0916576D0 (en) 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
KR101793758B1 (ko) * 2010-02-24 2017-11-03 시네론 메디컬 리미티드 체형 교정 장치
US8806615B2 (en) 2010-11-04 2014-08-12 Mcafee, Inc. System and method for protecting specified data combinations
US10220078B2 (en) 2014-06-11 2019-03-05 The Board Of Regents Of The University Of Texas System Methods of using thrombin derivatives to treat medulloblastoma
CZ308845B6 (cs) * 2019-01-21 2021-07-07 Globetech Innovation S.R.O Farmaceutická směs topicky hojivých peptidových složek pro použití k topické léčbě kožních defektů a/nebo k topickému hojení ran

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352664A (en) 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
AU5638096A (en) 1995-06-07 1996-12-30 Clarion Pharmaceuticals, Inc. Non-biological patch for hemostasis
GB9930768D0 (en) * 1999-12-29 2000-02-16 Pfizer Ltd Composition
CN100509055C (zh) * 2001-07-27 2009-07-08 奥索洛吉艾斯有限公司 使用凝血酶衍生的缩氨酸治疗慢性真皮溃疡

Also Published As

Publication number Publication date
US20040209819A1 (en) 2004-10-21
US7378500B2 (en) 2008-05-27
DE60212143D1 (de) 2006-07-20
DK1414487T3 (da) 2006-10-09
ATE328606T1 (de) 2006-06-15
EP1414487A2 (fr) 2004-05-06
JP2004538320A (ja) 2004-12-24
US7833982B2 (en) 2010-11-16
WO2003013569A2 (fr) 2003-02-20
US7049294B2 (en) 2006-05-23
CN100509055C (zh) 2009-07-08
US20060241049A1 (en) 2006-10-26
WO2003013569A3 (fr) 2003-12-11
DE60212143T2 (de) 2007-04-12
AU2002236768B2 (en) 2006-06-08
CA2455756A1 (fr) 2003-02-20
US20090029923A1 (en) 2009-01-29
ES2271216T3 (es) 2007-04-16
CN1556711A (zh) 2004-12-22
JP4192093B2 (ja) 2008-12-03
CA2455756C (fr) 2013-04-02
EP1414487B1 (fr) 2006-06-07

Similar Documents

Publication Publication Date Title
HK1065719A1 (en) Use of thrombin-derived peptides for the therapy of chronic dermal ulcers
MY180762A (en) Combination therapy comprising glucose reabsorption inhibitors and ppar modulators.
MY148432A (en) Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators.
UA88500C2 (ru) Многослойная повязка, пригодная для сокращения продолжительности процесса заживления ран
GB2382305B (en) Absorbent wound dressings containing a hydrogel layer
PL368683A1 (en) A wound dressing
AU3802900A (en) A pressure relieving dressing
DK1349856T3 (da) Isoindolin-1-on-glucokinase-aktivatorer
ATE358510T1 (de) Vorrichtung zur iontophoretischen verabreichung von medikamenten durch das augenlid
NO20053042L (no) Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi.
WO2003045494A3 (fr) Therapies faisant appel a l'imiquimod
WO2006114105A3 (fr) Methodes permettant de traiter les saignements
WO2001078703A3 (fr) Methodes et compositions destinees a moduler l'activite des recepteurs adrenergiques alpha
SE0003537L (sv) Hudvänligt lim
AU2003301761A1 (en) Method for treating wounds to promote healing
DE60221884D1 (de) Mediziniscer verband
NO992674D0 (no) Konturen til et transdermalt terapeutisk system
WO2002024181A3 (fr) Utilisation de la melatonine pour induire une anesthesie generale
WO2001005445A3 (fr) Dispositif generant du dioxyde de carbone
WO2002072032A3 (fr) Composes et procedes d'identification, de stadification et de traitement de lymphome cutane a cellules t
WO2003070177A3 (fr) Utilisation d'analogues de la melatonine aux fins d'induction d'une anesthesie generale
SE0101725D0 (sv) Förbandshållare
AU2003231480A1 (en) Communication system, server device used in communication system, communication device, and program for executing communication method of the communication device
WO1996007421A3 (fr) Medicament anti-ulcereux comprenant une proteine ayant une activite de facteur de croissance cellulaire et un inhibiteur de la pompe a protons
UA49495A (uk) Спосіб лікування переломів кісток

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140116